论文信息 - Efficacy and safety of alflutinib (AST2818) in patients with T790M mutation-positive NSCLC: A phase IIb multicenter single-arm study. - 字舞流文

Efficacy and safety of alflutinib (AST2818) in patients with T790M mutation-positive NSCLC: A phase IIb multicenter single-arm study.

Ying Cheng | Dong Wang | Yuankai Shi | Yiping Zhang | Cheng Huang | Shucai Zhang | Zhiyong Ma | Hui Zhao | Xiaodong Zhang | Xingsheng Hu | Lin Wu | Chunling Liu | Qitao Yu | D. Lv | Yong Jiang | H. Niu | J. Feng | Li Liu | Xiang Wang | Jing-zhang Li | Z. Ma | Zhang Xiaodong | C. Liu